Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
TNF neutralizing biologics infliximab (Inf) , and etanercept (Eta) have distinct clinical efficacy profiles.Infliximab, Etanercept, and Etanercept bioanalogitics belong to a class of drugs known as tumor necrosis factor α (TNFα) blockers (or anti-TNF α). An anti-TNF α product is a protein (antibody) that blocks a naturally occurring chemical in the body called tumor necrosis factor (TNF) , which can cause inflammation in the body. Such inflammation occurs when the body's immune system attacks its own tissues (autoimmune diseases).